Researchers studied 246 patients with new-onset CDI diagnosed at Minneapolis Veterans Affairs Medical Center from January 2004 through December 2006. Two infectious disease physicians evaluated the use of non-CDI antimicrobials (those that are inactive against C. diff), which they defined as unnecessary if not fully indicated.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Data showed 57 percent of patients received non-CDI antimicrobials during and/or after their CDI treatment, and 77 percent received at least one unnecessary antimicrobial dose. Twenty-six percent of patients received only unnecessary antimicrobials.
More Articles on C. diff:
Quidel Receives FDA Clearance for Handheld Molecular Diagnostic Test for C. Difficile
Illinois Publishes C. Diff, MRSA Data From Lab Tests for First Time
Study: Dog Correctly Detected C. Difficile in Patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.